Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 6Completed 5Active not recruiting 5Recruiting 2Not yet recruiting 2Withdrawn 1Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma, Large B-Cell, Diffuse 1

Interventions

fludarabine 1Rituximab 1R-CHOP protocol 1N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1Leukapheresis 1Lenalidomide 1Decitabine 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Enrolling by invitation × Lymphoma, Large B-Cell, Diffuse × R-CHOP protocol × Clear all
NCT07348575 2026-01-16

A Multicenter, Prospective, Randomized, Controlled Study of Decitabine in Combination With R-CHOP for Initial Treatment of EBV+ Diffuse Large B-cell Lymphoma

Second Affiliated Hospital of Nanchang University

Phase 3 Enrolling by invitation
80 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡